Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease.

Mildly increased serum bilirubin has recently been suggested as a protective factor, possibly reducing the risk of coronary artery disease (CAD) by acting as an antioxidant. We tested this hypothesis by examining serum bilirubin concentrations and other coronary risk factors in 120 men and 41 women with early familial CAD and 155 control subjects. At screening, both cases and control subjects were 38 to 68 years old. Early familial CAD patients had experienced myocardial infarction, coronary artery bypass grafting, or coronary angioplasty by age 55 years for men and 65 for women and had another sibling similarly affected. The average total serum bilirubin concentration was 8.9 +/- 6.1 mumol/L in cases and 12.4 +/- 8.1 mumol/L in control subjects (P = .0001 for difference). In univariate analysis stratified by sex, serum bilirubin was strongly and inversely related to CAD risk, with relative odds of 0.4 to 0.1 (relative to the lowest quintile, P = .04 to .00001) in both men and women as bilirubin increased into the upper two quintiles. Multiple logistic regression analysis was performed including age, sex, smoking, body mass index, diabetes, hypertension, plasma measured LDL cholesterol, HDL cholesterol, triglycerides, and serum bilirubin as potential risk factors. Bilirubin entered as an independent protective factor with an odds ratio of 0.25 (P = .0015) for an increase of 17 mumol/L (1 mg/dL). The standardized logistic regression coefficient for bilirubin was -.33 compared with -.34 for HDL, suggesting that the protective effect of bilirubin on CAD risk in the population is comparable to that of HDL cholesterol. A history of cigarette smoking was associated with significantly lower serum bilirubin concentration and appeared to attenuate the protective effect of bilirubin.

[1]  C. Mercke,et al.  Carbon monoxide production and reticulocyte count in normal women. Effect of contraceptive drugs and smoking. , 2009, Acta medica Scandinavica.

[2]  S. Hunt,et al.  Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[3]  J. Morrow,et al.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. , 1995, The New England journal of medicine.

[4]  D. L. Morris,et al.  Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. , 1994, JAMA.

[5]  R. Stocker,et al.  Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. , 1994, The Journal of biological chemistry.

[6]  S. Hunt,et al.  Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. , 1994, Clinical chemistry.

[7]  P. Seta,et al.  The antioxidant role of bile pigments evaluated by chemical tests. , 1994, Bioorganic & medicinal chemistry.

[8]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[9]  R. Stocker,et al.  Bilirubin attenuates radical‐mediated damage to serum albumin , 1993, FEBS letters.

[10]  E. Rimm,et al.  Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.

[11]  J. Manson,et al.  Vitamin E consumption and the risk of coronary disease in women. , 1993, The New England journal of medicine.

[12]  A. Waterhouse,et al.  Inhibition of human LDL oxidation by resveratrol , 1993, The Lancet.

[13]  H. Alessio,et al.  Oxygen-radical absorbance capacity assay for antioxidants. , 1993, Free radical biology & medicine.

[14]  E. Parks,et al.  Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine , 1993, The Lancet.

[15]  T. W. Wu,et al.  The cytoprotective effects of bilirubin and biliverdin on rat hepatocytes and human erythrocytes and the impact of albumin. , 1991, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[16]  T. W. Wu,et al.  Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage. , 1991, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[17]  D. Benaron,et al.  Variation of initial serum bilirubin rise in newborn infants with type of illness , 1991, The Lancet.

[18]  D. Harats,et al.  Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. , 1989, Atherosclerosis.

[19]  L. Jorde,et al.  Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices , 1989, Annals of human genetics.

[20]  L. Moore,et al.  Neonatal hyperbilirubinemia at high altitude. , 1989, American journal of diseases of children.

[21]  J. Lalouel,et al.  A rapid micro-scale procedure for determination of the total lipid profile. , 1989, Clinical chemistry.

[22]  S. Hunt,et al.  Family history as an independent risk factor for incident coronary artery disease in a high-risk cohort in Utah. , 1988, The American journal of cardiology.

[23]  S. Narumiya,et al.  Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  B. Ames,et al.  Antioxidant activity of albumin-bound bilirubin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[25]  B. Ames,et al.  Bilirubin is an antioxidant of possible physiological importance. , 1987, Science.

[26]  Sharma Sc.  Serum unconjugated bilirubin and free fatty acids in acute myocardial infarction and angina. , 1985 .

[27]  R. Conroy,et al.  Is a family history of coronary heart disease an independent coronary risk factor? , 1985, British heart journal.

[28]  Y. Friedlander,et al.  Family history of myocardial infarction as an independent risk factor for coronary heart disease. , 1985, British heart journal.

[29]  S Shea,et al.  Family history as an independent risk factor for coronary artery disease. , 1984, Journal of the American College of Cardiology.

[30]  T. W. Wu.  Bilirubin analysis--the state of the art and future prospects. , 1984, Clinical biochemistry.

[31]  T McLellan,et al.  Genetic distances between the Utah Mormons and related populations. , 1984, American journal of human genetics.

[32]  Y. Friedlander,et al.  Cigarette smoking and its relation to anthropometric characteristics and biochemical variables in Jerusalem 17-year-olds and adults. , 1982, Israel journal of medical sciences.

[33]  G. L. White,et al.  Fasting and gender (and altitude?) influence reference intervals for serum bilirubin in healthy adults. , 1981, Clinical chemistry.

[34]  M. Chan-yeung,et al.  The effects of age, smoking, and alcohol on routine laboratory tests. , 1981, American journal of clinical pathology.

[35]  E. Knoblock,et al.  Improved method for accurate quantitation of total and conjugated bilirubin in serum. , 1979, Clinical chemistry.

[36]  J. Griffiths,et al.  Patterns of enzyme activity following myocardial infarction and ischemia. , 1971, American journal of clinical pathology.

[37]  F. Ellis,et al.  Veganism, clinical findings and investigations. , 1970, The American journal of clinical nutrition.

[38]  K. Fung,et al.  Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. , 1994, Life sciences.

[39]  H. Schwertner,et al.  Association of low serum concentration of bilirubin with increased risk of coronary artery disease. , 1994, Clinical chemistry.

[40]  B. Ames,et al.  Antioxidant activities of bile pigments: biliverdin and bilirubin. , 1990, Methods in enzymology.

[41]  E. Barrett-Connor,et al.  Family history of stroke as an independent predictor of ischemic heart disease in men and stroke in women. , 1986, American journal of epidemiology.